As of November 2024 ImmunoPrecise Antibodies has a market cap of โน1.08 Billion. This makes ImmunoPrecise Antibodies the world's 9731th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 15th, 2024 the market cap of ImmunoPrecise Antibodies was reported to be: